Human colon cancer cells express the functional Fas ligand

Er Xun Ding, Akio Hizuta, Yoshinori Morimoto, Tohru Tanida, Toshie Hongo, Tatsuaki Ishii, Taketoshi Yamano, Toshiyoshi Fujiwara, Hiromi Iwagaki, Noriaki Tanaka

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)


Fas ligand (FasL) belongs to the TNF superfamily. It is induced in activated lymphocytes and eliminates Fas-positive lymphocytes, resulting in the down-regulation of immune responses. FasL has also been detected in tissues other than lymphoid cells. We investigated the expression and function of FasL on human colon cancer cells. FasL mRNA was detected by RT- PCR in all six colon cancer cell lines tested and was not found on fibroblasts. FasL protein was detected in DLD-1, LoVo, HCT-116 and RPMI 4788 cells by immunohistochemical staining. DLD-1, LoVo and WiDr were cytotoxic against mouse T lymphoma cells which were transfected with human Fas receptor cDNA. The cytotoxicity was significantly enhanced by phorbol 12-myristate 13- acetate (PMA) and ionomycin. Our data suggest that the FasL expressed in human colon cancer cells may be regulated by endogeneous factors in the microenvironment of the host and facilitates the escape from the host immune system.

Original languageEnglish
Pages (from-to)13-24
Number of pages12
JournalResearch Communications in Molecular Pathology and Pharmacology
Issue number1
Publication statusPublished - Jul 1 1998

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology


Dive into the research topics of 'Human colon cancer cells express the functional Fas ligand'. Together they form a unique fingerprint.

Cite this